Emgality 120

EMGALITY 120 mg, EMGALITY 240 mg, or placebo. All patients in the 120 mg EMGALITY group received an initial 240 mg loading dose. Patients

Emgality, Injection, solution, 120 mg, Subcutaneous, Eli Lilly Nederland B.V, , Not applicable, EU EU flag. Emgality, Solution, 120 mg / mL

withdrawal by subject). She was diagnosed with autoimmune EMGALITY 120 mg and 8.8 for EMGALITY 120 mg for Studies 1 and 2.

UNIT PRICE: PILL IMAGE: Emgality Syringe subcutaneous - 120 mg/mL solution: Emgality (galcanezumab) - 120 mg/mL injection: Emgality (galcanezumab) - 120 mg/mL injection:

Each single-dose prefilled syringe or pen contains 120 mg EMGALITY in 1 mL (120 mg/mL). Episodic Migraine in either EMGALITY Group (120 mg or

□ Emgality 120 mg/ml pen. □ Emgality 120 mg/ml syringe. □. Dose/directions. Quantity: Refills

EMGALITY 120 mg and 8.8 for EMGALITY 120 mg for Studies 1 and 2, Dose and Dose-Response. Please see justification for dose selection

She reported sleep disorder of mild severity starting the day of the first dose. EMGALITY 120 mg and 8.8 for EMGALITY 120 mg for

Dropouts and/or Discontinuations Due to Adverse Effects EMGALITY 120 mg and 8.8 for EMGALITY 120 mg for Studies 1 and 2, respectively